To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ARHGAP11ATABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
201 supporting clones for gene ARHGAP11A back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BX492339   .a 1 to 575 12 to 586   tiling clone,   575/586
(98 %)
6 diff
(99.0 %id)
BX492328   .a 2 to 570 12 to 580       569/580
(98 %)
6 diff
(99.0 %id)
DB080618 testis .a 46 to 616 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DA785010 brain .a 305 to 809 2 to 507   capped   506/506
(100 %)
2 diff
(99.7 %id)
DA545773   .a 319 to 885 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA475579   .a 326 to 889 2 to 565   capped   564/564
(100 %)
6 diff
(99.0 %id)
DB061798 testis .a 331 to 859 2 to 530   capped   529/529
(100 %)
3 diff
(99.5 %id)
DB226878 trachea .a 331 to 712 2 to 383   capped   382/382
(100 %)
1 diff
(99.8 %id)
BP284126 bone marrow .a 335 to 920 1 to 586       586/588
(99 %)
3 diff
(99.5 %id)
DA758127   .a 336 to 862 2 to 529   capped   528/528
(100 %)
2 diff
(99.7 %id)
CN306980 embryonic stem cells, cell lines H1, H7, andH9 .a 338 to 461 1 to 124       124/124
(100 %)
4 diff
(96.8 %id)
D87717 bone marrow .a 346 to 5960 1 to 5615 exact tiling clone, available from KIAA,   5615/5615
(100 %)
1 diff
(100.0 %id)
NM_014783.3   .a 346 to 5961 1 to 5616 exact RefSeq,   5616/5616
(100 %)
0 diff
(100 %id)
CV799959 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 351 to 1030 29 to 701       673/866
(77 %)
11 diff
(98.8 %id)
AL710650 human skeletal muscle .a 363 to 844 1 to 481       481/481
(100 %)
5 diff
(99.0 %id)
DA048369   .a 372 to 925 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA929241 small intestine .a 372 to 925 2 to 557   capped   556/556
(100 %)
4 diff
(99.3 %id)
CN306978 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 387 to 909 1 to 523       523/523
(100 %)
1 diff
(99.9 %id)
CN306985 embryonic stem cells, cell lines H1, H7, andH9 .a 389 to 588 11 to 210       200/210
(95 %)
6 diff
(97.2 %id)
BG258547 embryonal carcinoma, cell line, testis .a 389 to 1047 1 to 652       652/948
(68 %)
14 diff
(98.6 %id)
BC050545 Lymph, lymphoma .a 391 to 3292 1 to 2902   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 2902/2903
(99 %)
6 diff
(99.8 %id)
AL134883 melanoma (MeWo cell line) .a 392 to 720 1 to 329       329/330
(99 %)
3 diff
(99.1 %id)
BM479510 eye, retinoblastoma .a 395 to 1197 1 to 807   available from MGC,   807/1047
(77 %)
8 diff
(99.3 %id)
BM806829 lymph, lymphoma, cell line .a 395 to 1325 1 to 945   available from MGC,   883/1045
(84 %)
18 diff
(98.3 %id)
CN306977 embryonic stem cells, cell lines H1, H7, andH9 .a 402 to 913 1 to 512       512/512
(100 %)
0 diff
(100 %id)
BE244121 leukopheresis .a 410 to 529 1 to 120       120/121
(99 %)
10 diff
(91.8 %id)
BE246210 leukopheresis .a 410 to 744 1 to 335       335/354
(94 %)
8 diff
(97.8 %id)
DR003073 fetal brain .a 417 to 717 1 to 301       301/301
(100 %)
6 diff
(98.1 %id)
AL583259 B cells from Burkitt lymphoma .a 421 to 1354 1 to 922       922/922
(100 %)
32 diff
(96.6 %id)
BX344763   .a 421 to 1532 1 to 1097       1097/1152
(95 %)
28 diff
(97.6 %id)
CN306979 embryonic stem cells, cell lines H1, H7, andH9 .a 422 to 859 1 to 438       438/438
(100 %)
0 diff
(100 %id)
AL710086 human skeletal muscle .a 427 to 898 1 to 472       472/472
(100 %)
1 diff
(99.8 %id)
DA509075 brain .a 434 to 1012 2 to 580   capped   579/580
(99 %)
2 diff
(99.7 %id)
DA797078 brain .a 434 to 910 2 to 479   capped   478/478
(100 %)
2 diff
(99.6 %id)
DB135046 thymus .a 434 to 934 2 to 503   capped   502/502
(100 %)
1 diff
(99.9 %id)
BC039563 Uterus, leiomyosarcoma .a 491 to 4191 1 to 3701 exact available from MGC, AAA   3701/3701
(100 %)
1 diff
(100.0 %id)
BE889846 leiomyosarcoma, uterus .a 499 to 1035 1 to 540       540/540
(100 %)
3 diff
(99.5 %id)
AW504353.
matches multiple genes
lymph .a 513 to 911 4 to 400     also hits gene ARHGAP11B 397/400
(99 %)
9 diff
(97.8 %id)
BX472867   .a 541 to 856 1 to 316       316/316
(100 %)
4 diff
(98.8 %id)
AA093107   .a 692 to 951 1 to 254       254/265
(95 %)
24 diff
(91.0 %id)
AA355452   .a 744 to 886 1 to 143       143/143
(100 %)
2 diff
(98.7 %id)
AL710105 human skeletal muscle .a 807 to 1197 9 to 399       391/401
(97 %)
2 diff
(99.6 %id)
TI_1948231084   .a 1065 to 1926 135 to 995   AAA   861/1328
(64 %)
25 diff
(98.2 %id)
TI_1948231085   .a 1065 to 2010 124 to 1080       957/1293
(74 %)
34 diff
(97.4 %id)
TI_1948231330   .a 1065 to 2001 135 to 1070   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 936/1391
(67 %)
38 diff
(97.3 %id)
TI_1948231331   .a 1065 to 2146 124 to 1201       1013/1232
(82 %)
43 diff
(96.6 %id)
TI_1948231581   .a 1065 to 1903 137 to 977       841/1398
(60 %)
36 diff
(97.5 %id)
TI_1948231582   .a 1065 to 1924 125 to 984       860/1255
(68 %)
19 diff
(98.5 %id)
TI_1948231836   .a 1065 to 1792 138 to 868       731/1452
(50 %)
21 diff
(98.6 %id)
TI_1948231837   .a 1065 to 1927 124 to 988       865/1274
(67 %)
19 diff
(98.6 %id)
EL737081 mixed .a 1068 to 1743 1 to 676       676/676
(100 %)
2 diff
(99.8 %id)
BX370780   .a 1110 to 2004 1 to 900       899/900
(99 %)
14 diff
(98.5 %id)
BF925264.
matches multiple genes
nervous_tumor .a 1182 to 1670 522 to 33     Submitted on the opposite strand, also hits gene ARHGAP11B 490/522
(93 %)
24 diff
(95.5 %id)
BX372467   .a 1196 to 1981 784 to 1       784/970
(80 %)
9 diff
(99.1 %id)
BX480697   .a 1275 to 1897 1 to 623       623/623
(100 %)
0 diff
(100 %id)
CN306987 embryonic stem cells, DMSO-treated H9 cellline .a 1628 to 2060 1 to 433       433/433
(100 %)
1 diff
(99.8 %id)
AA374666 lung .a 1644 to 1912 1 to 269       269/273
(98 %)
3 diff
(99.0 %id)
AW963725   .a 1645 to 2178 1 to 534       534/539
(99 %)
8 diff
(98.6 %id)
DB153777 thymus .a 1697 to 2268 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
AL706339 human skeletal muscle .a 1809 to 2410 1 to 602       602/602
(100 %)
2 diff
(99.7 %id)
BE882351 leiomyosarcoma, uterus .a 1831 to 2548 1 to 717       717/905
(79 %)
13 diff
(98.6 %id)
BU430514 lymph .a 1910 to 2452 7 to 549       543/549
(98 %)
7 diff
(98.8 %id)
BU430520 lymph .a 1910 to 2399 7 to 496       490/496
(98 %)
7 diff
(98.6 %id)
TI_154151888   .a 1910 to 2590 79 to 758       680/681
(99 %)
9 diff
(98.7 %id)
TI_154151941   .a 1910 to 2529 79 to 696       618/675
(91 %)
19 diff
(97.2 %id)
AW504476 lymph .a 1949 to 2501 1 to 553       553/555
(99 %)
6 diff
(99.0 %id)
CD655857 Embryonic Stem cells .a 1956 to 2695 12 to 752       741/824
(89 %)
18 diff
(97.9 %id)
TI_154160627   .a 1956 to 2664 81 to 784       704/708
(99 %)
13 diff
(98.2 %id)
DB073096 testis .a 1968 to 2507 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
BU429214 lymph .a 2076 to 2453 8 to 385       378/385
(98 %)
6 diff
(98.5 %id)
TI_154150228   .a 2076 to 2485 80 to 489       410/962
(42 %)
8 diff
(99.2 %id)
BG531190 embryonal carcinoma, testis .a 2099 to 2885 1 to 785       785/785
(100 %)
6 diff
(99.3 %id)
DA760071   .a 2179 to 2724 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
AW069704 bone marrow stroma .a 2185 to 2529 1 to 356     Submitted on the opposite strand 356/403
(88 %)
12 diff
(97.1 %id)
CN306982 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2271 to 2970 1 to 700       700/700
(100 %)
1 diff
(99.9 %id)
BF083718 colon .a 2311 to 2739 431 to 3       429/431
(99 %)
1 diff
(99.8 %id)
BM819192 stomach .a 2360 to 2929 1 to 569       569/569
(100 %)
1 diff
(99.9 %id)
CX751683 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2394 to 3178 1 to 780     Submitted on the opposite strand 780/787
(99 %)
13 diff
(98.4 %id)
AW364697 denis_drash .a 2406 to 2806 28 to 428       401/440
(91 %)
7 diff
(98.5 %id)
DA653708   .a 2552 to 3098 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
CN306986 embryonic stem cells, cell lines H1, H7, andH9 .a 2606 to 3300 1 to 694       694/694
(100 %)
1 diff
(99.9 %id)
DA664808   .a 2654 to 3203 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
AA865748 germinal center B cell .a 2777 to 3281 503 to 2       502/503
(99 %)
0 diff
(100 %id)
AW297913   .a 2782 to 3170 401 to 13   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 389/401
(97 %)
0 diff
(100 %id)
BP335248 coronary artery .a 2783 to 3363 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BP337444 coronary artery .a 2783 to 3364 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP291674 lung .a 2784 to 3366 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DA653840   .a 2786 to 3331 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
BF212574 bone marrow, from chronic myelogenous leukemia .a 2787 to 3451 1 to 671       671/908
(73 %)
62 diff
(93.2 %id)
AA355707   .a 2796 to 3075 1 to 280       280/280
(100 %)
0 diff
(100 %id)
AW953516   .a 2797 to 3484 1 to 690       690/690
(100 %)
10 diff
(98.6 %id)
AA749411 germinal center B cell .a 2813 to 3170 365 to 5       361/365
(98 %)
0 diff
(100 %id)
BQ436597 epithelioid carcinoma, Pancreas .a 2817 to 3674 48 to 915       868/939
(92 %)
42 diff
(95.6 %id)
DA437150 tongue, tumor tissue .a 2829 to 3435 2 to 609   capped   608/608
(100 %)
1 diff
(99.9 %id)
BG680136 skin, squamous cell carcinoma .a 2829 to 3600 1 to 778       778/778
(100 %)
23 diff
(97.1 %id)
BE719937 head_neck .a 2887 to 3143 259 to 3       257/259
(99 %)
0 diff
(100 %id)
AA747560 germinal center B cell .a 2889 to 3281 391 to 2       390/391
(99 %)
0 diff
(100 %id)
AA830619 germinal center B cell .a 2899 to 3275 381 to 6       376/381
(98 %)
0 diff
(100 %id)
AA687979 germinal center B cell .a 2911 to 3179 269 to 1       269/269
(100 %)
0 diff
(100 %id)
CB116462 Liver .a 2952 to 3593 1 to 642       642/642
(100 %)
0 diff
(100 %id)
DA031658   .a 2955 to 3414 2 to 464   capped   463/463
(100 %)
4 diff
(99.2 %id)
CB145148 Liver .a 2969 to 3332 1 to 365       365/365
(100 %)
1 diff
(99.8 %id)
BP221014 colon .a 2994 to 3543 1 to 550       550/550
(100 %)
5 diff
(99.1 %id)
CN306983 embryonic stem cells, DMSO-treated H9 cellline .a 3010 to 3187 1 to 178       178/178
(100 %)
1 diff
(99.5 %id)
DA644444   .a 3021 to 3598 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DA550279   .a 3123 to 3693 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
BQ430719 large cell carcinoma, lung .a 3124 to 4204 22 to 1095       1074/1101
(97 %)
41 diff
(96.3 %id)
DA554422   .a 3183 to 3741 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA603699   .a 3264 to 3776 2 to 514   capped   513/513
(100 %)
0 diff
(100 %id)
BM791397 stomach .a 3287 to 3933 1 to 647       647/647
(100 %)
0 diff
(100 %id)
BG286436 bladder, transitional cell papilloma, cell line .a 3288 to 4026 1 to 743       743/891
(83 %)
16 diff
(98.3 %id)
AI525703 Prostate .a 3300 to 3864 11 to 583       573/946
(60 %)
5 diff
(99.5 %id)
CN306981 embryonic stem cells, DMSO-treated H9 cellline .a 3324 to 3932 1 to 609       609/609
(100 %)
0 diff
(100 %id)
BU959461 mixed (pool of 40 RNAs) .a 3385 to 4034 1 to 658       658/735
(89 %)
17 diff
(97.7 %id)
BP203168 coronary artery .a 3447 to 4013 1 to 567       567/567
(100 %)
3 diff
(99.5 %id)
BQ774758 Bone, Human Chondrosarcoma Cell Line .a 3448 to 4191 761 to 19   AAA   743/743
(100 %)
1 diff
(99.9 %id)
BG171104 hypernephroma, cell line, Kidney .a 3486 to 4241 1 to 747       747/947
(78 %)
29 diff
(97.0 %id)
BG260215 bladder, transitional cell papilloma, cell line .a 3515 to 4115 1 to 597       597/597
(100 %)
4 diff
(99.4 %id)
AW379820 head_neck .a 3564 to 4122 1 to 561       561/561
(100 %)
10 diff
(98.3 %id)
CA419850 Bone, Human Chondrosarcoma Cell Line .a 3581 to 4188 628 to 19   AAA   610/610
(100 %)
3 diff
(99.6 %id)
AW362531 colon .a 3597 to 3751 1 to 156       156/156
(100 %)
2 diff
(98.8 %id)
BP312303 brain .a 3602 to 4184 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
CX781209 human embryonic stem cells .a 3653 to 4471 1 to 819       819/819
(100 %)
0 diff
(100 %id)
AA091457   .a 3684 to 3864 1 to 181       181/181
(100 %)
5 diff
(97.3 %id)
AA249167   .a 3684 to 3883 1 to 200       200/200
(100 %)
1 diff
(99.5 %id)
BQ218492 melanotic melanoma, skin .a 3693 to 4556 1 to 866       866/873
(99 %)
10 diff
(98.9 %id)
AW379825 head_neck .a 3756 to 4120 1 to 365       365/365
(100 %)
5 diff
(98.7 %id)
BG115586 duodenal adenocarcinoma, cell line, small intestine .a 3758 to 4475 16 to 734       719/974
(73 %)
18 diff
(98.2 %id)
BE541779 cervix .a 3841 to 4524 1 to 688       688/730
(94 %)
16 diff
(97.9 %id)
CN306984 embryonic stem cells, DMSO-treated H9 cellline .a 3896 to 4482 1 to 587       587/587
(100 %)
2 diff
(99.7 %id)
AI952245 lung, two pooled squamous cell carcinomas .a 3931 to 4197 306 to 40   AAA   267/267
(100 %)
20 diff
(92.6 %id)
DA479407   .a 3977 to 4429 2 to 454   capped   453/453
(100 %)
2 diff
(99.6 %id)
BI253479 cervical carcinoma cell line, cervix .a 3983 to 4834 1 to 849       849/851
(99 %)
14 diff
(98.4 %id)
CA489585   .a 3985 to 4862 1 to 895       895/898
(99 %)
24 diff
(97.4 %id)
CX871863 embryonic stem .a 4007 to 4783 1 to 777       777/777
(100 %)
1 diff
(99.9 %id)
CX787801 human embryonic stem cells .a 4102 to 4892 1 to 791       791/791
(100 %)
2 diff
(99.8 %id)
BU943144 mixed (pool of 40 RNAs) .a 4166 to 4942 1 to 792       792/792
(100 %)
29 diff
(96.4 %id)
BM477883 leiomyosarcoma, uterus .a 4288 to 4833 1 to 550       550/1002
(54 %)
15 diff
(98.6 %id)
BG117627 adenocarcinoma, cell line, Liver .a 4356 to 4539 533 to 712       657/980
(67 %)
51 diff
(94.8 %id)
BF211645 bone marrow, from chronic myelogenous leukemia .a 4591 to 5326 1 to 730       730/914
(79 %)
39 diff
(95.8 %id)
BE566372 bladder, carcinoma, cell line .a 4592 to 5151 1 to 562       562/563
(99 %)
4 diff
(99.3 %id)
AW608918 pnet .a 4601 to 5258 666 to 13       654/705
(92 %)
0 diff
(100 %id)
AW608962 pnet .a 4601 to 5258 666 to 13       654/705
(92 %)
0 diff
(100 %id)
CX781137 human embryonic stem cells .a 4602 to 5277 701 to 25   AAA   677/677
(100 %)
4 diff
(99.5 %id)
D20287   .a 4603 to 4837 1 to 230     Submitted on the opposite strand 230/230
(100 %)
6 diff
(97.4 %id)
AW876615 pnet .a 4604 to 5236 644 to 11       634/730
(86 %)
0 diff
(100 %id)
AW876614 pnet .a 4610 to 5261 676 to 27       650/688
(94 %)
0 diff
(100 %id)
AW608883 pnet .a 4620 to 5261 637 to 1       637/637
(100 %)
29 diff
(95.5 %id)
AW608927 pnet .a 4620 to 5261 637 to 1       637/637
(100 %)
29 diff
(95.5 %id)
BQ775253 Bone, Human Chondrosarcoma Cell Line .a 4623 to 5332 728 to 19   AAA   710/710
(100 %)
3 diff
(99.6 %id)
BQ000398 Fibrosarcoma .a 4654 to 5332 697 to 19   AAA   679/679
(100 %)
0 diff
(100 %id)
BQ773138 Chondrosarcoma Cell line .a 4654 to 5279 644 to 19   AAA   626/626
(100 %)
1 diff
(99.9 %id)
CN306988 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 4667 to 5277 1 to 612   AAA   612/612
(100 %)
2 diff
(99.7 %id)
BM990266 lung, Metastatic Chondrosarcoma .a 4669 to 5332 682 to 19   AAA   664/664
(100 %)
1 diff
(99.9 %id)
BG435148 placenta .a 4771 to 5332 1 to 562   AAA   562/562
(100 %)
1 diff
(99.9 %id)
BU959925 mixed (pool of 40 RNAs) .a 4813 to 5278 1 to 465       465/501
(92 %)
3 diff
(99.5 %id)
AW167446 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 4880 to 5332 463 to 13   AAA   451/451
(100 %)
1 diff
(99.8 %id)
BM988404 lung, Metastatic Chondrosarcoma .a 4895 to 5332 456 to 19   AAA   438/438
(100 %)
0 diff
(100 %id)
CD242228 Blood vessels - aorta, basilar and artery .a 4906 to 5577 1 to 679       679/782
(86 %)
31 diff
(96.1 %id)
CA337307 posterior rhombomeres 5-8 (4 pooled) .a 4927 to 5333 1 to 408       408/408
(100 %)
6 diff
(98.6 %id)
CB160287 Liver .a 4929 to 5279 390 to 40   AAA Submitted on the opposite strand 351/360
(97 %)
3 diff
(99.2 %id)
AA215362 germinal center B cell .a 5005 to 5468 1 to 466       466/467
(99 %)
4 diff
(99.2 %id)
AA262370 germinal center B cell .a 5006 to 5274 1 to 269       269/269
(100 %)
0 diff
(100 %id)
BE246271 leukopheresis .a 5014 to 5330 319 to 3       317/319
(99 %)
0 diff
(100 %id)
FN076743 breast carcinoma .a 5084 to 5189 107 to 5     Submitted on the opposite strand 103/111
(92 %)
0 diff
(100 %id)
FN161579 breast carcinoma .a 5196 to 5305 107 to 1     Submitted on the opposite strand 107/111
(96 %)
3 diff
(97.3 %id)
AI858837 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 5521 to 5958 452 to 14   AAA   439/439
(100 %)
1 diff
(99.8 %id)
AA129627 lung, lung carcinoma .a 5557 to 5934 9 to 386       378/386
(97 %)
0 diff
(100 %id)
BF130847 hypernephroma, Kidney .a 5704 to 6231 1 to 520       520/529
(98 %)
11 diff
(98.0 %id)
AA779687   .a 5724 to 6243 523 to 4   tiling clone,   520/523
(99 %)
0 diff
(100 %id)
AW292145   .a 5775 to 6233 476 to 18   AAA   459/469
(97 %)
2 diff
(99.6 %id)
BG117554 adenocarcinoma, cell line, Liver .a 5814 to 5959 1 to 146       146/160
(91 %)
1 diff
(99.4 %id)
AA214499 germinal center B cell .a 5976 to 6233 258 to 1   tiling clone,   258/258
(100 %)
2 diff
(99.3 %id)
AK303025 testis .b 1 to 3152 1 to 3152 exact tiling clone,   3152/3152
(100 %)
0 diff
(100 %id)
DC404292 testis .b 1 to 572 1 to 572       572/572
(100 %)
0 diff
(100 %id)
AK316437 testis .c 1 to 3318 1 to 3318   tiling clone,   3318/3318
(100 %)
3 diff
(100.0 %id)
DB094142 testis .c 2 to 550 2 to 550   capped   549/549
(100 %)
2 diff
(99.7 %id)
BG773522 testis .c 36 to 808 6 to 776   tiling clone,   771/776
(99 %)
12 diff
(98.5 %id)
NM_199357.1   .d 1 to 2470 1 to 2470 exact RefSeq, AAA   2470/2470
(100 %)
0 diff
(100 %id)
BC063444 Eye, retinoblastoma .d 50 to 2470 1 to 2421 exact tiling clone, available from MGC, AAA   2421/2421
(100 %)
0 diff
(100 %id)
AW674067 cervix .d 1052 to 1325 1 to 276       276/276
(100 %)
5 diff
(98.2 %id)
TI_1948231838   .d 1288 to 2227 1067 to 128       940/1364
(68 %)
36 diff
(97.4 %id)
TI_1948231583   .d 1394 to 2227 965 to 129       837/1359
(61 %)
17 diff
(98.8 %id)
TI_1948231086   .d 1432 to 2227 919 to 130       790/1280
(61 %)
12 diff
(99.1 %id)
TI_1948231332   .d 1432 to 2227 922 to 130       793/1358
(58 %)
5 diff
(99.7 %id)
BU622339 Cell Line, Chondrosarcoma .d 1753 to 2470 735 to 19   AAA   717/718
(99 %)
1 diff
(99.9 %id)
BF969255 adrenal cortex carcinoma, cell line, adrenal gland .d 1858 to 2470 1 to 612   AAA   612/612
(100 %)
1 diff
(99.9 %id)
BY798844 eye .d 1940 to 2471 1 to 531       531/531
(100 %)
1 diff
(99.9 %id)
AW673856 cervix .d 2001 to 2470 480 to 11   AAA   470/470
(100 %)
1 diff
(99.8 %id)
CR625523 B cells (Ramos cell line) Cot 25-normalized .e 1 to 2279 1 to 2279 exact tiling clone,   2279/2279
(100 %)
0 diff
(100 %id)
BX344762   .e 1188 to 2276 1087 to 1       1087/1187
(91 %)
18 diff
(98.5 %id)
AL583211 B cells from Burkitt lymphoma .e 1315 to 2276 964 to 4       961/1043
(92 %)
27 diff
(97.5 %id)
BM834084 stomach .f 1 to 625 1 to 625 exact tiling clone,   625/625
(100 %)
0 diff
(100 %id)
DB118491 thymus .g 1 to 571 2 to 572 N87S tiling clone, capped   571/571
(100 %)
1 diff
(99.9 %id)
AA806195 germinal center B cell .h-u 1 to 414 415 to 2 exact tiling clone,   414/415
(99 %)
0 diff
(100 %id)
BI024985 marrow .h-u 387 to 762 1 to 376   tiling clone,   376/376
(100 %)
9 diff
(97.7 %id)
DA758648   .i 1 to 567 2 to 569   tiling clone, capped   568/568
(100 %)
2 diff
(99.7 %id)
BQ320717.
matches multiple genes
colon .i 512 to 736 9 to 244 A11S P12T N13K L14S L15S ... tiling clone, also hits gene ARHGAP11B 236/269
(87 %)
29 diff
(89.3 %id)
BX494342 Liver .j-u 1 to 573 1 to 572 exact tiling clone,   572/572
(100 %)
1 diff
(99.9 %id)
BQ027243 mixed .j-u 13 to 504 1 to 492 exact tiling clone, Submitted on the opposite strand 492/492
(100 %)
2 diff
(99.6 %id)
DB068819 testis .k 1 to 547 2 to 549 I14H L15S L16A Y17V Q18P ... tiling clone, capped   548/548
(100 %)
2 diff
(99.7 %id)
DB085141 testis .l -8 to 538 2 to 548 exact tiling clone, capped   547/547
(100 %)
1 diff
(99.9 %id)
AW407786 lymph .m 1 to 258 1 to 258 H2R tiling clone,   258/258
(100 %)
5 diff
(98.1 %id)
BF667193 brain, primitive neuroectoderm Gene ARHGAP11A, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i, .j-u, .k, .l, .m Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI